CD4 and neoplasm: Moreover, there were no differences in the percentages of CD3+ T lymphocytes and CD4+ T lymphocytes at 21 days after operation between the non-tumor-bearing group and the IRE group, and the ratio of CD4+/CD8+ in the IRE group was higher than that in non-tumor-bearing group, although this difference was not statistically significant (P>0.05).